Fosun International Ltd

Q4 2020 13F Holdings Report, Stock Holdings

Signature - Title
Angel Sze - Company Secretary
Location
Hong Kong, China
Holdings as of
December 31, 2020
Value $
$1.17B
Num holdings
190
Date filed
2/5/2021, 06:04 AM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q3 2020 - Nov 12, 2020
Next filing
Q1 2021 - May 11, 2021
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2020 Q4 compared to 2020 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Angel Sze Company Secretary Hong Kong, Hong Kong 2/5/2021

Other Included Managers (4):

Num Name Location File Number
1 Fidelidade-Companhia de Seguros, S.A. Lisboa, Portugal 028-16288
2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 028-18303
3 Hauck & Aufhaeuser Fund Services S.A. 028-18996
4 AMERITRUST GROUP, INC. 028-20162